Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy

• Main Authors: Leiliane Rodrigues Marcatto (Author), Luciana Sacilotto (Author), Letícia Camargo Tavares (Author), Debora Stephanie Pereira Souza (Author), Natália Olivetti (Author), Celia Maria Cassaro Strunz (Author), Francisco Carlos Costa Darrieux (Author), Maurício Ibrahim Scanavacca (Author), Jose Eduardo Krieger (Author), Alexandre Costa Pereira (Author), Paulo Caleb Junior Lima Santos (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundWarfarin is the most common oral anticoagulant drug, especially in low-income and emerging countries, because of the high cost of direct oral anticoagulant (DOACs), or when warfarin is the only proven therapy (mechanical prosthetic valve and kidney dysfunction). The quality of warfarin the...